MEK1 is required for the development of NRAS-driven leukemia

Joanna D. Nowacka; Christian Baumgartner; Cristiana Pelorosso; Mareike Roth; Johannes Zuber; Manuela Baccarini

doi:10.18632/oncotarget.12555

MEK1 is required for the development of NRAS-driven leukemia

Joanna D. Nowacka, Christian Baumgartner, Cristiana Pelorosso, Mareike Roth, Johannes Zuber, Manuela Baccarini

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	80113-80130
Number of pages	18
Journal	Onco Target
Volume	7
Issue number	49
DOIs	https://doi.org/10.18632/oncotarget.12555
Publication status	Published - 2016

Austrian Fields of Science 2012

301904 Cancer research

Keywords

Leukemia
MEK1
MYC
NRAS
leukemia
ACTIVATION
MYELOPROLIFERATIVE DISORDERS
RAS
ACUTE MYELOID-LEUKEMIA
PREMATURE SENESCENCE
RAS/RAF/MEK/ERK PATHWAY
HEMATOPOIETIC STEM-CELLS
IN-VIVO
MUTATIONS
ERK PHOSPHORYLATION

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.12555Licence: CC BY 3.0

Cite this

@article{73132104b7e441d3b61fc995b4599cc1,

title = "MEK1 is required for the development of NRAS-driven leukemia",

keywords = "Leukemia, MEK1, MYC, NRAS, leukemia, ACTIVATION, MYELOPROLIFERATIVE DISORDERS, RAS, ACUTE MYELOID-LEUKEMIA, PREMATURE SENESCENCE, RAS/RAF/MEK/ERK PATHWAY, HEMATOPOIETIC STEM-CELLS, IN-VIVO, MUTATIONS, ERK PHOSPHORYLATION",

author = "Nowacka, {Joanna D.} and Christian Baumgartner and Cristiana Pelorosso and Mareike Roth and Johannes Zuber and Manuela Baccarini",

year = "2016",

doi = "10.18632/oncotarget.12555",

language = "English",

volume = "7",

pages = "80113--80130",

journal = "Onco Target",

issn = "1949-2553",

publisher = "IMPACT JOURNALS LLC",

number = "49",

}

TY - JOUR

T1 - MEK1 is required for the development of NRAS-driven leukemia

AU - Nowacka, Joanna D.

AU - Baumgartner, Christian

AU - Pelorosso, Cristiana

AU - Roth, Mareike

AU - Zuber, Johannes

AU - Baccarini, Manuela

PY - 2016

Y1 - 2016

KW - Leukemia

KW - MEK1

KW - MYC

KW - NRAS

KW - leukemia

KW - ACTIVATION

KW - MYELOPROLIFERATIVE DISORDERS

KW - RAS

KW - ACUTE MYELOID-LEUKEMIA

KW - PREMATURE SENESCENCE

KW - RAS/RAF/MEK/ERK PATHWAY

KW - HEMATOPOIETIC STEM-CELLS

KW - IN-VIVO

KW - MUTATIONS

KW - ERK PHOSPHORYLATION

UR - http://www.scopus.com/inward/record.url?scp=85001033115&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12555

DO - 10.18632/oncotarget.12555

M3 - Article

AN - SCOPUS:85001033115

SN - 1949-2553

VL - 7

SP - 80113

EP - 80130

JO - Onco Target

JF - Onco Target

IS - 49

ER -

MEK1 is required for the development of NRAS-driven leukemia

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Role of MEK1 signaling in the regulation of hematopoiesis and leukemogenesis

Cite this

MEK1 is required for the development of NRAS-driven leukemia

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Projects

Role of MEK1 signaling in the regulation of hematopoiesis and leukemogenesis

Cite this